Dr. Edward Ashton

• 
  www.clinica.co.uk/blog/standardisation_so_important_for - [Cached Version]
  Published on: 9/26/2008    Last Visited: 10/2/2008  

  Ed Ashton, chief scientific officer of Rochester, US-based image analysis firm VirtualScopics, said this was especially important in phase I studies, where there is a low number of patients and investigators are usually only looking for one or two responders.
  
  Spurious positive results (such as smaller tumour size or decreased metabolism) could push an unsuccessful drug forward, while false negatives could kill off promising candidates, he explained.
  
  "Moral duty"
  
  There is also the ethical issue of exposing patients to high doses of radiation who probably will not ultimately benefit from the data they generate.
  
  Dr Ashton said researchers had a moral duty to honour these patients' contributions rather than being forced to discard their data because of technical reasons.Some CT scans can deliver radiation doses higher than the US annual federal limit of 50mSv, he pointed out, which could cause secondary cancers.

• 
  www.virtualscopics.com/executive-management.aspx - [Cached Version]
  Published on: 7/22/2008    Last Visited: 7/22/2008  

  Edward Ashton, Ph.D. - Chief Scientific OfficerEdward Ashton is responsible for the scientific and algorithm development for the applications for VirtualScopics.He has extensive custom software development experience in both biomedical imaging and military surveillance and reconnaissance.Dr. Ashton is a frequent speaker at international imaging conferences and has authored many peer-reviewed publications of his research at VirtualScopics.Prior to VirtualScopics, he was a lead signal processing engineer at The MITRE Corporation in McLean, VA. Earlier in his career, Dr. Ashton spent three years as a research engineer with the Naval Research Laboratory, where he received the Alan Berman Research Publication Award and was nominated for the Edison Award for Applied Science.Dr. Ashton has produced numerous articles on target detection and image analysis with military applications, including a chapter on hyperspectral target identification in the recently published textbook Information Processing for Remote Sensing.He received both his Ph.D. and M.S. degrees in electrical engineering from the University of Rochester, and his B.S. degree in electrical engineering from Loyola College.Additionally, he was a National Science Foundation Graduate Fellow as well as a Sproul Fellow at the University of Rochester.

• 
  www.imaging.org/conferences/icis06/program.cfm - [Cached Version]
  Published on: 10/13/2008    Last Visited: 3/7/2007  

  Edward A. Ashton, VirtualScopics, Inc. (USA)

• 
  4th Annual Medical Imaging for Clinical Trials - CBI... - [Cached Version]
  Published on: 12/17/2003    Last Visited: 8/22/2006  

  Edward Ashton, Ph.D., Vice President, Product Development, VirtualScopics

• 
  Biospace.com - [Cached Version]
  Published on: 10/12/2006    Last Visited: 10/13/2006  

  , a leading developer of image-based biomarker solutions, announced today that Edward Ashton, chief scientific officer, will present key results related to imaging system quality assurance for clinical trials at the upcoming Drug Information Association (DIA) medical imaging workshop, to be held October 12th - 13th at the Renaissance Washington, DC Hotel.
  ...
  "The data in our presentation shows that implementing a quantitative imaging component in a clinical trial without strict quality controls, beyond what are provided by the device manufacturers, is likely to result in a great deal of wasted time and money with no real return," said Dr. Ashton.

• 
  CHI's Molecular Medicine Tri-Conference 2007 - Track 4... - [Cached Version]
  Published on: 5/14/2005    Last Visited: 10/8/2006  

  Edward Ashton, Ph.D., Chief Scientific Officer, VirtualScopics, Inc. The field of medical imaging is undergoing a radical shift, from subjective interpretation to quantitative analysis and measurement.

• 
  Can Medical Image Analysis Change the Economics of... - [Cached Version]
  Published on: 7/7/2004    Last Visited: 9/10/2008  

  Ashton is vice president of product development at VirtualScopics. Edward Ashton can be reached at VirtualScopics, 350 Linden Oaks, Rochester, New York 14625 USA.Tel. 585-249-6231 ext. 212; e-mail ashton@virtualscopics.com
  ...
  Ashton, C. Takahashi, M.J. Berg et al., J. Magn.Reson.Imaging 17, 300-308 (2003).

• 
  Democrat & Chronicle: Business - [Cached Version]
  Published on: 11/13/2005    Last Visited: 11/13/2005  

  The four panelists were Steve Scott, vice president of technology at Reflexite Corp.; David Glocker, president of Isoflux Inc.; John Hart, CEO of Lumetrics Inc.; and Edward Ashton of VirtualScopics Inc.
  ...
  Said Ashton of VirtualScopics: "We're creating a new market, so it's incumbent upon us to make sure it's difficult for other people to get in."

• 
  Democrat & Chronicle: Business - [Cached Version]
  Published on: 10/11/2005    Last Visited: 10/11/2005  

  Dr. Edward Ashton of VirtualScopics, the technology's inventor, said it allows more accurate and reproducible image analyses in oncology, cardiology and neurology.

• 
  EETimes.com - Press Release - VirtualScopics Receives... - [Cached Version]
  Published on: 9/18/2006    Last Visited: 9/19/2006  

  "This innovation provides up to a 30% improvement in measurement precision over older techniques, allowing clinical trials to achieve significant results with fewer experimental subjects followed over shorter periods of time," said Dr. Edward Ashton, chief scientific officer of VirtualScopics and its inventor.
  ...
  "VirtualScopics congratulates Dr. Ashton on this important achievement for the benefit of both our company and drug development during clinical trials."

Page:  1 2 3